ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for HR+/HER2- Breast Cancer
Sites in Sarasota, Tampa +13 more locations
Sponsor: Avenzo Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06998407·Phase 1, Phase 2·Recruiting·Listed May 2025